TheEdgeResearch
Home / Stocks / OSSFF

Embla Medical hf. (OSSFF)

OTC Healthcare Medical - Devices
$4.15 ▲ +0.00%
Market Cap
$1.77B
Sector
Healthcare
Industry
Medical - Devices
Beta
0.46
52-Wk Range
4.15-5.325
CEO
Sveinn Solvason
Country
IS
Currency
USD

Embla Medical hf. operates in the Medical - Devices industry of the Healthcare sector, headquartered in Reykjavik, SU, IS. The stock last traded at $4.15, up 0.00% on the session, giving a market capitalisation of $1.77B. On trailing twelve-month figures it carries a trailing P/E of 18.93, a net margin of 9.5%. Its beta of 0.46 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
18.93
Price / Sales
1.80
Price / Book
1.94
EV / EBITDA
10.83
Gross margin
60.3%
Operating margin
13.7%
Net margin
9.5%
Return on equity
Debt / equity
0.58
Current ratio
1.25
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
4,192
IPO date
2019-05-23
Headquarters
Reykjavik, SU, IS
About Embla Medical hf.

Embla Medical hf is a global enterprise dedicated to the orthopaedic sector. Its primary focus involves the conceptualization, progression, manufacturing, and international distribution of non-surgical orthopaedic solutions. The company's business activities are geographically divided into three main regions: the Americas; Europe, the Middle East, and Africa (EMEA); and the Asia-Pacific territory. Established in 1971 by Össur Kristinsson, Embla Medical hf maintains its corporate headquarters in Reykjavík, Iceland.

Comparable companies

Embla Medical hf. is most often compared with the following Healthcare names:

ALFRYDMPHFGGNDFGNNDYHBMHFMEDGFSHPHFSTSEYTCGGYVTRLY
More research on OSSFF
OSSFF technical analysis OSSFF TheEdge Score Compare against peers
Open full interactive analysis & DCF →